Trial Profile
Safety and efficacy of conditioning regimen with fludarabine and targeted dose intravenous busulfan for elderly patinets
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2022
Price :
$35
*
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Transplant rejection
- Focus Therapeutic Use
- 07 Nov 2022 Status changed from active, no longer recruiting to completed.
- 22 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Apr 2013 New trial record